Ivan Oransky

Articles by Ivan Oransky

The Scientist Placeholder Image

Profiting from insider clinical data

The Scientist Placeholder Image

First dog cloned

The Scientist Placeholder Image

Ivory-billed woodpecker spotted; plays tennis

The Scientist Placeholder Image

The 'miracle' of the ivory-billed woodpecker

The Scientist Placeholder Image

USDA: no pet cloning regulation

The Scientist Placeholder Image

Please Stop, You're Interfering With My Research

The Scientist Placeholder Image

Your Next Job in Pharma

The Scientist Placeholder Image

Simple Language: Just What We Ordered

The Scientist Placeholder Image

Spring has Sprung

The Scientist Placeholder Image

The Petri dish of security

The Scientist Placeholder Image

US firm and antivivisectionists in cat fight

The Scientist Placeholder Image

War of the clones

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies